Radiofrequency ablation of pathologically proven T1a renal tumors: 15 years follow up—A tertiary cancer center experience.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.4582
Abstract: 4582Background: To evaluate the long term oncologic efficacy and overall survival of radiofrequency ablation (RFA) for pathologically proven T1a Renal cell carcinoma (RCC). Methods: we retrospectively reviewed our renal ablation data base between January 2001… read more here.
Keywords: ablation; proven t1a; pathologically proven; t1a renal ... See more keywords